What is Epsilon Molecular Engineering?
Epsilon Molecular Engineering, based in Saitama, Japan, is a notable player in the biotechnology and biomolecules development space. The company focuses on advancing molecular engineering solutions, contributing to innovation within the life sciences industry. Its strategic positioning suggests a commitment to cutting-edge research and development, aiming to address complex challenges through advanced biological technologies.
How much funding has Epsilon Molecular Engineering raised?
Epsilon Molecular Engineering has raised a total of $5.5M across 1 funding round:
Series A
$5.5M
Series A (2020): $5.5M with participation from Real Tech Fund and Mitsubishi UFJ Lease & Finance Company Limited
Key Investors in Epsilon Molecular Engineering
Real Tech Fund
Real Tech Fund is a venture capital firm established in 2014, specializing in investments in research and development-focused technology companies.
Mitsubishi UFJ Lease & Finance Company Limited
Mitsubishi UFJ Lease & Finance Company Limited is a financial services entity that participated in this funding round.
What's next for Epsilon Molecular Engineering?
With the recent major enterprise-level funding, Epsilon Molecular Engineering is poised for accelerated growth and strategic initiatives. This capital infusion is expected to fuel further research, expand its development capabilities, and potentially explore new market opportunities. The company's focus on biomolecules development suggests a pipeline of innovative products or services that could redefine aspects of the biotechnology landscape. Future endeavors will likely involve scaling operations and solidifying its market presence.
See full Epsilon Molecular Engineering company page
